CatalystPit

BNTXBioNTech SE

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $98.30 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-09 · Sahin Ugur (Chief Executive Officer) · SELL
  • 2026-10-07 · Sahin Ugur (Chief Executive Officer) · SELL
  • 2026-10-06 · Sahin Ugur (Chief Executive Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders305
Shares held49,065,142
Value$4.24B
Percent of shares outstanding19.53%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2024-04-15 · Hon. Josh Gottheimer · BUY · $1,001 - $15,000
  • 2023-12-06 · Hon. Josh Gottheimer · BUY · $1,001 - $15,000
  • 2023-12-05 · Hon. Josh Gottheimer · BUY · $1,001 - $15,000
RECENT NEWS
  • BioNTech SE: Moving Past Covid
  • BioNTech to close German manufacturing plants after failing to find buyers
  • Pfizer, BioNTech, Moderna fail to dismiss mRNA patent lawsuits
  • Pfizer, BioNTech and Moderna lose bid to dismiss Bayer patent case
  • BioNTech to close three German sites
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
BioNTech SE (BNTX) · Stock Price, Insider Trades, Congress Trades · CatalystPit